Randomized clinical trials with run-in periods: frequency, characteristics and reporting

References

• Pablos-MéndezABarrRGSheaSRun-in periods in randomized trials: implications for the application of results in clinical practiceJAMA199827932222259438743
   PubMed Web of Science ®Google Scholar
• TalleyNJJanssensJLauritsenKRáczIBolling-SternevaldEEradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months’ follow upBMJ1999318718783383710092259
   PubMed Web of Science ®Google Scholar
• Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER), Center for Devices and Radiological Health (CDRH)Draft guidance for industry: enrichment strategies for clinical trials to support approval of human drugs and biological products Available from: http://www.fda.gov/downloads/drugs/guid-ancecomplianceregulatoryinformation/guidances/ucm332181.pdf. Published December 2012Accessed April 9, 2017
   Google Scholar
• HaleMKhanAKutchMLiSOnce-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back painCurr Med Res Opin20102661505151820429852
   PubMed Web of Science ®Google Scholar
• LangJMBuringJERosnerBCookNHennekensCHEstimating the effect of the run-in on the power of the physicians’ health studyStat Med19911010158515931947514
   PubMed Web of Science ®Google Scholar
• RANDOM.ORGInteger generator Available from: https://www.random.org/integers/Accessed November 22, 2018
   Google Scholar
• Google Translate Available from: https://translate.google.com/Accessed November 22, 2018
   Google Scholar
• Performing real statistical analysis using Excel Available from: http://www.real-statistics.com/Accessed November 29, 2018
   Google Scholar
• AngelinBKristensenJDErikssonMReductions in serum levels of LDL cholesterol, apolipoprotein B, triglycerides and lipoprotein(a) in hypercholesterolaemic patients treated with the liver-selective thyroid hormone receptor agonist eprotiromeJ Intern Med2015277333134224754313
   PubMed Web of Science ®Google Scholar
• BleeckerERLötvallJO’ByrnePMFluticasone furoatevilanterol 100-25 mcg compared with fluticasone furoate 100 mcg in asthma: a randomized trialJ Allergy Clin Immunol Pract20142555356125213048
   PubMed Web of Science ®Google Scholar
• CasabéARoehrbornCGda PozzoLFEfficacy and safety of the coadministration of tadalafil once daily with finasteride for 6 months in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasiaJ Urol2014191372773324096118
   PubMed Web of Science ®Google Scholar
• ChurchABeeraheeMBrooksJMehtaRShahPDose response of umeclidinium administered once or twice daily in patients with COPD: a randomised cross-over studyBMC Pulm Med2014141224393134
   PubMed Web of Science ®Google Scholar
• De BoeverEHAshmanCCahnAPEfficacy and safety of an anti-IL-13 mAb in patients with severe asthma: a randomized trialJ Allergy Clin Immunol2014133498999624582316
   PubMed Web of Science ®Google Scholar
• DiamondMPCarrBDmowskiWPElagolix treatment for endo-metriosis-associated pain: results from a Phase 2, randomized, double-blind, placebo-controlled studyReprod Sci201421336337123885105
   PubMed Web of Science ®Google Scholar
• DodickDWGoadsbyPJSpieringsELSchererJCSweeneySPGrayzelDSSafety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a Phase 2, randomised, double-blind, placebo-controlled studyLancet Neurol201413988589225127173
   PubMed Web of Science ®Google Scholar
• FitzpatrickSLJefferyRJohnsonKCBaseline predictors of missed visits in the look AHEAD studyObesity201422113114023996977
   PubMed Web of Science ®Google Scholar
• HaabFBraticeviciBKrivoborodovGPalmasMZufferli RussoMPietraCEfficacy and safety of repeated dosing of netupitant, a neurokinin-1 receptor antagonist, in treating overactive bladderNeurourol Urodyn201433333534023765630
   PubMed Web of Science ®Google Scholar
• HalmosEPChristophersenCTBirdARShepherdSJGibsonPRMuirJGDiets that differ in their FODMAP content alter the colonic luminal microenvironmentGut20156419310025016597
   PubMed Web of Science ®Google Scholar
• HanhinevaKLankinenMAPedretANontargeted metabolite profiling discriminates diet-specific biomarkers for consumption of whole grains, fatty fish, and bilberries in a randomized controlled trialJ Nutr2015145171725527657
   PubMed Web of Science ®Google Scholar
• HoareJCareyPJoskaJACarraraHSorsdahlKSteinDJEscitalopram treatment of depression in human immunodeficiency virus/acquired immunodeficiency syndrome: a randomized, double-blind, placebo-controlled studyJ Nerv Ment Dis2014202213313724469525
   PubMed Web of Science ®Google Scholar
• JuliusSEganBMKacirotiNANesbittSDChenAKTROPHY InvestigatorsIn prehypertension leukocytosis is associated with body mass index but not with blood pressure or incident hypertensionJ Hypertens201432225125924275841
   PubMed Web of Science ®Google Scholar
• LaurentSBoutouyriePVascular Mechanism CollaborationDose-dependent arterial destiffening and inward remodeling after olmesartan in hypertensives with metabolic syndromeHypertension201464470971625001274
   PubMed Web of Science ®Google Scholar
• ManeechotesuwanKAssawabhumiJRattanasaengloetKSuthamsmaiTPipopsuthipaiboonSUdompunturakSComparison between the effects of generic and original salmeterol/fluticasone combination (SFC) treatment on airway inflammation in stable asthmatic patientsJ Med Assoc Thai201497Suppl 3S91S10024772585
   PubMedGoogle Scholar
• MarreroDPanQBarrett-ConnorEImpact of diagnosis of diabetes on health-related quality of life among high risk individuals: the Diabetes Prevention Program outcomes studyQual Life Res2014231758823709097
   PubMed Web of Science ®Google Scholar
• MartinezCHMoyMLNguyenHQTaking healthy steps: rationale, design and baseline characteristics of a randomized trial of a pedometer-based Internet-mediated walking program in veterans with chronic obstructive pulmonary diseaseBMC Pulm Med20141411224491137
   PubMed Web of Science ®Google Scholar
• MugieSMKorczowskiBBodiPPrucalopride is no more effective than placebo for children with functional constipationGastroenterology201414761285129525239590
   PubMed Web of Science ®Google Scholar
• OluleyeOWRectorTSWinSHistory of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fractionCirc Heart Fail20147696096625225241
   PubMed Web of Science ®Google Scholar
• PoulsenSKDueAJordyABHealth effect of the New Nordic Diet in adults with increased waist circumference: a 6-mo randomized controlled trialAm J Clin Nutr2014991354524257725
   PubMed Web of Science ®Google Scholar
• ReznikYCohenOAronsonRInsulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trialLancet201438499501265127224998009
   PubMed Web of Science ®Google Scholar
• SaneeiPHashemipourMKelishadiREsmaillzadehAThe Dietary Approaches to Stop Hypertension (DASH) diet affects inflammation in childhood metabolic syndrome: a randomized cross-over clinical trialAnn Nutr Metab2014641202724686130
   PubMed Web of Science ®Google Scholar
• SiproudhisLJonesDShingRNWalkerDScholefieldJHLibertas Study ConsortiumLibertas: rationale and study design of a multicentre, Phase II, double-blind, randomised, placebo-controlled investigation to evaluate the efficacy, safety and tolerability of locally applied NRL001 in patients with faecal incontinenceColorectal Dis201416Suppl 1596624499497
   PubMed Web of Science ®Google Scholar
• van GoolJDde JongTPWinkler-SeinstraPMulti-center ran-domized controlled trial of cognitive treatment, placebo, oxybutynin, bladder training, and pelvic floor training in children with functional urinary incontinenceNeurourol Urodyn201433548248723775924
   PubMed Web of Science ®Google Scholar
• ZhuDGaoPHoltbrueggeWHuangCA randomized, double-blind study to evaluate the efficacy and safety of a single-pill combination of telmisartan 80 mg/amlodipine 5 mg versus amlodipine 5 mg in hypertensive Asian patientsJ Int Med Res2014421526624391142
   PubMed Web of Science ®Google Scholar
• TrivediMHRushHDoes a placebo run-in or a placebo treatment cell affect the efficacy of antidepressant medications?Neuropsychopharmacology199411133437945742
   PubMed Web of Science ®Google Scholar
• KatzNEnriched enrollment randomized withdrawal trial designs of analgesics: focus on methodologyClin J Pain200925979780719851161
   PubMed Web of Science ®Google Scholar
• McQuayHJDerrySMooreRAPoulainPLegoutVEnriched enrolment with randomised withdrawal (EERW): time for a new look at clinical trial design in chronic painPain2008135321722018258369
   PubMed Web of Science ®Google Scholar
• HudmonKSChamberlainRMFrankowskiRFOutcomes of a placebo run-in period in a head and neck cancer chemoprevention trialControl Clin Trials19971832282409204223
   PubMedGoogle Scholar
• PerkovicVJoshiRPatelABompointSChalmersJADVANCE Collaborative GroupADVANCE: lessons from the run-in phase of a large study in type 2 diabetesBlood Press200615634034617472024
   PubMed Web of Science ®Google Scholar
• FukuokaYGayCHaskellWAraiSVittinghoffEIdentifying factors associated with dropout during prerandomization run-in period from an mHealth physical activity education study: the mPED trialJMIR Mhealth Uhealth201532e3425872754
   PubMed Web of Science ®Google Scholar
• UlmerMRobinaughDFriedbergJPLipsitzSRNatarajanSUsefulness of a run-in period to reduce drop-outs in a randomized controlled trial of a behavioral interventionContemp Clin Trials200829570571018565801
   PubMed Web of Science ®Google Scholar
• WallineJJJonesLAMuttiDOZadnikKUse of a run-in period to decrease loss to follow-up in the Contact Lens and Myopia Progression (CLAMP) studyControl Clin Trials200324671171814662276
   PubMedGoogle Scholar
• GreenbergRPFisherSRiterJAPlacebo washout is not a meaningful part of antidepressant drug trialsPercept Mot Skills19958126886908570378
   PubMed Web of Science ®Google Scholar
• LeeSWalkerJRJakulLSextonKDoes elimination of placebo responders in a placebo run-in increase the treatment effect in randomized clinical trials? A meta-analytic evaluationDepress Anxiety2004191101914978780
   PubMed Web of Science ®Google Scholar
• AffusoOKaiserKACarsonTLAssociation of run-in periods with weight loss in obesity randomized controlled trialsObes Rev2014151687324118736
   PubMed Web of Science ®Google Scholar
• FurlanAChaparroLEIrvinEMailis-GagnonAA comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer painPain Res Manag201116533735122059206
   PubMed Web of Science ®Google Scholar
• KramerMSShapiroSHScientific challenges in the application of randomized trialsJAMA198425219273927456492351
   PubMed Web of Science ®Google Scholar
• BaileyKRGeneralizing the results of randomized clinical trialsControl Clin Trials199415115238149769
   PubMedGoogle Scholar
• TreweekSZwarensteinMMaking trials matter: pragmatic and explanatory trials and the problem of applicabilityTrials20091013719493350
   PubMed Web of Science ®Google Scholar
• FranciosaJACommentary on the use of run-in periods in clinical trialsAm J Cardiol199983694294410190414
   PubMed Web of Science ®Google Scholar
• HewittDJHoTWGalerBImpact of responder definition on the enriched enrollment randomized withdrawal trial design for establishing proof of concept in neuropathic painPain2011152351452121185118
   PubMed Web of Science ®Google Scholar
• SchrollJBPenningaEIGøtzschePCAssessment of adverse events in protocols, clinical study reports, and published papers of trials of orlistat: a document analysisPLoS Med2016138e100210127529343
   PubMed Web of Science ®Google Scholar
• LeberPDDavisCSThreats to the validity of clinical trials employing enrichment strategies for sample selectionControl Clin Trials19981921781879551282
   PubMedGoogle Scholar
• HigginsJSterneJSavovićJA revised tool for assessing risk of bias in randomized trialsCochrane Database Syst Rev201610Suppl 12931
   Google Scholar
• RothwellPMExternal validity of randomised controlled trials: “to whom do the results of this trial apply?”Lancet20053659453829315639683
   PubMed Web of Science ®Google Scholar
• MannHDjulbegovicBComparator bias: why comparisons must address genuine uncertaintiesJ R Soc Med20131061303323358277
   PubMed Web of Science ®Google Scholar
• RochonPAGurwitzJHSimmsRWA study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritisArch Intern Med199415421571638285810
   PubMedGoogle Scholar
• SaferDJDesign and reporting modifications in industry-sponsored comparative psychopharmacology trialsJ Nerv Ment Dis2002190958359212357091
   PubMed Web of Science ®Google Scholar
• PincusTRheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trialsJ Clin Epidemiol19884111103710413060568
   PubMed Web of Science ®Google Scholar
• HeneghanCGoldacreBMahtaniKRWhy clinical trial outcomes fail to translate into benefits for patientsTrials201718112228288676
   PubMed Web of Science ®Google Scholar
• RothwellPMFactors that can affect the external validity of randomised controlled trialsPLoS Clin Trials200611e916871331
   PubMedGoogle Scholar
• CharlsonMEHorwitzRIApplying results of randomised trials to clinical practice: impact of losses before randomisationBr Med J (Clin Res Ed)1984289645412811284
   PubMed Web of Science ®Google Scholar
• LundhALexchinJMintzesBSchrollJBBeroLIndustry sponsorship and research outcomeCochrane Database Syst Rev20172MR00003328207928
   PubMed Web of Science ®Google Scholar
• HopewellSDuttonSYuLMChanAWAltmanDGThe quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMedBMJ2010340c72320332510
   PubMed Web of Science ®Google Scholar
• MillsEJWuPGagnierJDevereauxPJThe quality of randomized trial reporting in leading medical journals since the revised CONSORT statementContemp Clin Trials200526448048716054580
   PubMed Web of Science ®Google Scholar
• HewittCHahnSTorgersonDJWatsonJBlandJMAdequacy and reporting of allocation concealment: review of recent trials published in four general medical journalsBMJ200533074991057105815760970
   PubMed Web of Science ®Google Scholar
• AltmanDGMoherDSchulzKFImproving the reporting of randomised trials: the CONSORT Statement and beyondStat Med201231252985299722903776
   PubMed Web of Science ®Google Scholar
• SchulzKFAltmanDGMoherDCONSORT GroupCONSORT 2010 statement: updated guidelines for reporting parallel group randomised trialsBMJ2010340c33220332509
   PubMed Web of Science ®Google Scholar
• MoherDHopewellSSchulzKFCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsBMJ2010340c86920332511
   PubMed Web of Science ®Google Scholar
• ChanAWTetzlaffJMAltmanDGSPIRIT 2013 statement: defining standard protocol items for clinical trialsAnn Intern Med2013158320020723295957
   PubMed Web of Science ®Google Scholar
• ChanAWTetzlaffJMGøtzschePCSPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trialsBMJ2013346e758623303884
   PubMed Web of Science ®Google Scholar